Tyndall National Institute announce R&D collaboration with West Pharmaceutical Services

Tyndall National Institute today announced that they have signed a Research & Development (R&D) collaboration agreement with West Pharmaceutical Services, Inc., to work on future developments of drug delivery systems for injectable medicines.

The collaboration will apply Tyndall’s world leading multidisciplinary research in Information and Communication Technology (ICT) to a range of transformational medical devices in development at West. This will enable West, a global leader in the design and manufacture of drug containment and delivery systems, to meet emerging trends in the healthcare industry.

“This is an exciting opportunity for West to engage with Tyndall National Institute,” said Chris Evans, VP Innovation, West. “We are delighted to collaborate with one of Europe’s leading ICT research centers and look to bolster our research and development footprint in Ireland. We have been impressed by the talented team that has come together to devise the joint-proposal and are grateful to the Irish funding body who has recognized the vision and technology we are set to co-develop.”

The two-year project will employ a team of postdoctoral researchers, who will be working at Tyndall in partnership with West. This highly collaborative project is to be co-funded by an Enterprise Ireland Innovation Partnership with IDA support.

Carlo Webster, Senior Strategic Business Executive, Tyndall National Institute, commented, “The Tyndall–West collaboration has arrived at the right time and at the intersection between healthcare and ICT fields. It is becoming increasingly apparent with each new generation of products coming on to the market that smart systems are required. The collaboration is a perfect example of where West identifies unmet needs from the market and partners with Tyndall to deliver the technical competency and innovative solutions that are required.”

“We look forward to developing technologies that will help improve how patients take their medicines in the future. West is an excellent partner for the team and their vision is aligned with the research team at Tyndall.” said Dr. Conor O’Mahony, Senior Research Scientist and Project Lead.

West has a presence in Ireland and employs more than 700 people across two different manufacturing sites in Dublin and Waterford.